The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery.
Andre LamyWesley TongRajibul MianJessica VincentWojciech SzczeklikBruce M BiccardEmmanuelle DuceppeMaria Graza FranzosiSadeesh K SrinathanChristian S MeyhoffJoel ParlowDenis XavierP J DevereauxPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
ClinicalTrials.gov identifier number NCT01661101.